That was the single largest amount specifically delineated by the plan, according to the Foundation for Taxpayer and Consumers Rights, which posted a press release on the plan even before the plan was available on CIRM's own web site.
The foundation said $451 million was recommended for clinical trials, with costs shared with industry.
John M. Simpson, stem cell project director for the foundation, said:
"During the Proposition 71 campaign, proponents implied that miraculous cures were just around the corner. This plan acknowledges just how difficult the task ahead is and is a welcome change from the hype that has all too often been associated with stem cell research. Californians are entitled to an honest assessment of the prospects for research they are funding."The draft will be discussed at the Oversight Committee meetings in Los Angeles later this month. Final approval is scheduled for December.
We will have more on this later today when the plan becomes publicly available.
(Editor's note: An earlier version of this said $423 million was recommended for bridging the gap between the lab and clinic.) Sphere: Related Content